Cedric Pobel, MD

Cedric Pobel, MD, is a medical oncologist, PhD student, Institut de Cancérologie, Gustave Roussy, Paris, France.

Articles

Pobel Translates PEACE-1 Trial Results Into Clinical Practice for mCSPC

April 8th 2025

Cedric Pobel, MD, discusses how the results of the PEACE-1 trial support the use of radiotherapy plus standard of care and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Findings From the PEACE-1 Trial in mCRPC

Cedric Pobel, MD

March 17th 2025

Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Behind the Design of the PEACE-1 Trial in mCSPC

Cedric Pobel, MD

January 10th 2025

Cedric Pobel, MD, discusses the design and objectives of the phase 3 PEACE-1 trial for patients with de novo metastatic castration-sensitive prostate cancer.